Market Cap (In USD)
2.87 Million
Revenue (In USD)
5.2 Million
Net Income (In USD)
-13.41 Million
Avg. Volume
11.75 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.336-30.5
- PE
- -
- EPS
- -
- Beta Value
- 0.135
- ISIN
- US74754R2022
- CUSIP
- 74754R103
- CIK
- 1460702
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Michael S. Poirier
- Employee Count
- -
- Website
- https://www.qualigeninc.com
- Ipo Date
- 2015-06-23
- Details
- Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
More Stocks
-
0KXM
-
0I4TCriteo S.A.
0I4T
-
ECLERXeClerx Services Limited
ECLERX
-
0JCB
-
300212
-
BALMLAWRIEBalmer Lawrie & Co. Ltd.
BALMLAWRIE
-
JISLJALEQSJain Irrigation Systems Limited
JISLJALEQS
-
SGRY